Inito, a startup based out of India’s Bengaluru, has just raised $6M in order to help women track fertility hormones right at their homes. They explain that “With other standard tests, you get “yes/no” results, and you need to use different test strips to track fertile days and confirm ovulation.
Inito provides numerical values of your fertility hormones and personalizes results to your body. It gives your full fertile window of six days and also confirms if you actually ovulate by looking at the rise in progesterone metabolite PdG.
“Unlike other products that leave the interpretation of hormone values to the user, our app looks at the evolution of four hormones together and determines if the fertility rating for that day is low, high or peak and if ovulation has indeed occurred in this cycle”. “With the latest advancements in AI, we have taken this one step further by explaining why a result was given in natural language.”
Inito’s CEO Aayush Rai said, “While fertility hormone testing is our first product, this funding raise will allow us to invest in R&D for new tests that cater to solving problems faced by both patients and practitioners”. “We are building point-of-care tests for tracking pregnancy health, ovarian reserve and male fertility hormones. Our technology uses a combination of hardware, biotechnology and machine learning to improve the accuracy, reliability and density of test strips allowing them to measure multiple parameters on a single testing platform.”